- Home
- TKLF vs INM Comparison
TKLF vs INM Comparison
Compare TKLF & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TKLF | INM |
|---|---|---|
| Founded | 2006 | 1981 |
| Country | Japan | Canada |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.3M | 7.1M |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | TKLF | INM |
|---|---|---|
| Price | $1.63 | $1.36 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 6.5K | ★ 61.1K |
| Earning Date | 12-19-2025 | 05-12-2026 |
| Dividend Yield | ★ 10.97% | N/A |
| EPS Growth | N/A | ★ 62.68 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,942,633.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $2.82 | ★ N/A |
| Revenue Growth | N/A | ★ 7.50 |
| 52 Week Low | $1.60 | $0.58 |
| 52 Week High | $3.92 | $2.50 |
Technical Indicators
Market Signals| Indicator | TKLF | INM |
|---|---|---|
| Relative Strength Index (RSI) | 39.82 | 46.90 |
| Support Level | N/A | $1.35 |
| Resistance Level | $2.43 | $1.40 |
| Average True Range (ATR) | 0.11 | 0.06 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 14.12 | 43.12 |
Price Performance
Historical ComparisonAbout TKLF Yoshitsu Co. Ltd
Tokyo Lifestyle Co Ltd is a retailer and wholesaler of Japanese beauty and health products, sundry products, electronic products, and other products. It sells its products through directly operated physical stores, online stores, and franchise stores and wholesale customers. It operates through directly operated physical stores, online stores and services, and franchise stores and wholesale customers segments, with the franchise stores and wholesale customers segment generating maximum revenue. Geographically, it generates maximum revenue from Hong Kong.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.